{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["120(5)"],"submitter":["Woods A"],"funding":["National Drug and Alcohol Research Centre"],"pubmed_abstract":["<h4>Background and aims</h4>Substance use (SU) is prevalent among individuals in the criminal justice system (CJS). However, there is often poor access to treatment. We aimed to assess the effectiveness of two medications, extended-release naltrexone (XR-NTX) and extended-release buprenorphine (XR-BUP) for the prison population.<h4>Methods</h4>We searched Scopus, OVID/Embase, PubMed/Medline, ProQuest, EBSCO, Cochrane Library and Australian Criminology Database for original articles published from 1 January 2002 to 31 December 2022.<h4>Inclusion criteria</h4>18+, substance use disorder; XR treatment; recent incarceration. We extracted study, participants, treatment characteristics and outcome variables. We conducted risk of bias assessments using the RoB-2, ROBINS-I, JBI tools and Evers et "],"journal":["Addiction (Abingdon, England)"],"pagination":["835-859"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11986285"],"repository":["biostudies-literature"],"pubmed_title":["Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review."],"pmcid":["PMC11986285"],"pubmed_authors":["Woods A","Shakeshaft A","Foley C","Doyle M","Asare-Doku W","Settumba-Stolk S","Conigrave KM","Farrell M"],"additional_accession":[]},"is_claimable":false,"name":"Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review.","description":"<h4>Background and aims</h4>Substance use (SU) is prevalent among individuals in the criminal justice system (CJS). However, there is often poor access to treatment. We aimed to assess the effectiveness of two medications, extended-release naltrexone (XR-NTX) and extended-release buprenorphine (XR-BUP) for the prison population.<h4>Methods</h4>We searched Scopus, OVID/Embase, PubMed/Medline, ProQuest, EBSCO, Cochrane Library and Australian Criminology Database for original articles published from 1 January 2002 to 31 December 2022.<h4>Inclusion criteria</h4>18+, substance use disorder; XR treatment; recent incarceration. We extracted study, participants, treatment characteristics and outcome variables. We conducted risk of bias assessments using the RoB-2, ROBINS-I, JBI tools and Evers et ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2025-07-12T03:04:20.109Z","creation":"2025-07-12T03:04:20.109Z"},"accession":"S-EPMC11986285","cross_references":{"pubmed":["39888117"],"doi":["10.1111/add.16766"]}}